SAREPTA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
SAREPTA THERAPEUTICS, INC. (SRPT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 488.19 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-03-02
- SAREPTA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 488.19K shares, a 47.08% increase from fiscal 2024.
- SAREPTA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 331.92K shares, a 72.02% decline from fiscal 2023.
- SAREPTA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.19M shares, a 33.25% decline from fiscal 2022.
- SAREPTA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.78M shares, a 5.43% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|
| 2025-12-31 | 488.19K shares 10-K · filed 2026-03-02 |
| 2024-12-31 | 331.92K shares 10-K · filed 2025-02-28 |
| 2023-12-31 | 1.19M shares 10-K · filed 2024-02-28 |
| 2022-12-31 | 1.78M shares 10-K · filed 2023-02-28 |
| 2021-12-31 | 1.69M shares 10-K · filed 2022-03-01 |
| 2020-12-31 | 1.40M shares 10-K · filed 2021-03-01 |
| 2019-12-31 | 1.43M shares 10-K · filed 2021-03-01 |
| 2018-12-31 | 2.15M shares 10-K · filed 2021-03-01 |
| 2017-12-31 | 4.81M shares 10-K · filed 2020-02-26 |
| 2016-12-31 | 1.29M shares 10-K · filed 2019-02-28 |
| 2015-12-31 | 2.83M shares 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |